Inside these posts: Kaletra

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.

 

Glaxo-Abbott case handed to the jury

A jury began deliberating Friday morning on whether Abbott Laboratories should pay GlaxoSmithKline hundreds of millions of dollars over allegations of unfair HIV drug pricing. Get the full story »

Glaxo lawyer: Abbott used HIV drug as weapon

Abbott Laboratories improperly hiked the price of one drug to help it preserve sales growth of one of its other HIV blockbusters, an attorney for GlaxoSmithKline told a jury. Get the full story »

Glaxo: Abbott has illegal monopoly in AIDS drugs

From Bloomberg News | GlaxoSmithKline Plc lawyers, in a trial seeking at least $1.5 billion in damages, told jurors that Abbott Laboratories had an illegal monopoly over HIV drugs. Get the full story>>

India rejects Abbott patent of Kaletra AIDS drug

Abbott Laboratories was refused copyright protection on its AIDS drug Kaletra by India‚Äôs patent office, allowing Cipla Ltd. and other generic-drug companies to continue selling copies. Get the full story »